Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致
Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.